If expensive medical check-ups can’t detect cancer, perhaps a tube of blood can~
– News and Information Report –
“When you expect a physical exam costing a few hundred yuan to diagnose every ailment, while a single ailment test costs thousands or even tens of thousands of yuan, do you think that’s possible?” iKang CEO Zhang Ligang uttered this statement at a media briefing on July 30th, instantly sparking outrage online.
Angry netizens shouted: “Is this even human language? If you don’t like the idea of a few hundred yuan, you can just not buy the package.” But when the emotions faded, we have to admit that this much-criticized CEO was only half right.
PART 01
The harsh reality of physical examinations: the “design flaws” of cheap packages
– Frontline Report –
Opening the iKang Guobin mini-program, one is bombarded with advertisements for “99 yuan pre-employment physical exams” and “399 yuan annual health protection packages.” These low-priced packages harbor three hidden traps:
- Key items were excluded: The 499 yuan “Classic Cancer Prevention Package” only includes two tumor marker tests, CEA and AFP, while effective screening methods such as colonoscopy, gastroscopy, and low-dose CT have all been eliminated. Ironically, CEA has a detection rate of less than 15% for early-stage cancer and is completely ineffective for kidney cancer. The 2022 edition of the “Guidelines for the Diagnosis and Treatment of Renal Cell Carcinoma” clearly states: “Currently, there are no recognized serum tumor markers for the early diagnosis of renal cell carcinoma.”
- Equipment and consumables were reduced: The low-priced package uses domestically produced reagents that are over 30% less sensitive than imported products. DR machines from more than a decade ago can’t even detect 5mm lung nodules, while low-dose CT scans at tertiary hospitals cost six times that much.
- Examinations have become mere formalities: The average examination time per patient is less than three minutes. Abdominal ultrasounds only examine three sections, while professional guidelines require at least eight—”like servicing a car and only checking the tires without opening the hood.”
PART 02
The core of misunderstanding: physical examination ≠ cancer screening
– Core Analysis –
Amid the public outcry, a key point has been overlooked: the core value of routine physical exams is chronic disease prevention and control, not early cancer screening.
The true mission of a physical exam is to identify controllable risks in blood pressure, blood sugar, and blood lipids, and to prevent disease progression through lifestyle interventions. Zhang Ligang’s attempt to convey the logic that “physical exams ≠ medical treatment” is valid in itself—but using “cost theory” to justify missed diagnoses is a blasphemy against medical responsibility.
The deeper contradiction lies in this: when physical exam institutions break down effective measures like enhanced CT scans (1,200 yuan) into high-priced add-ons and use low-cost packages to attract customers, they compromise the bottom line of medicine. The false sense of security consumers harbor in receiving a “no abnormalities” report is more dangerous than not getting a physical exam at all.
PART 03
Breakthrough moment: When early screening technology overcomes the “cost trap”
If routine physical exams can’t solve the challenge of early cancer screening, are we left to sit and wait? No! Technological innovation is reshaping the rules of the game.
HymonBio’s Pan-Cancer Screening Test Kit breaks through traditional barriers with a revolutionary solution:
➤ Target 28 common cancers with a single tube of blood: Only 5mL of peripheral blood is needed, covering over 85% of common cancers (including kidney cancer, for which serum markers are lacking)!
➤ Methylation Analysis: By detecting over 400 gene methylation related to cancer, we can identify cancerous signals at the gene expression level, providing early warning of risks 3-5 years earlier than traditional methods!
➤ Affordable Pricing: The test costs only 4% of similar products in the United States, making accurate early screening affordable!
Life’s Choice: Cheap Comfort vs. Real Protection
Zhang Ligang actually got half the truth right: a few hundred-yuan medical checkup certainly doesn’t always detect cancer. However, the other half of the truth is: technological innovation has made accurate early screening affordable.
While medical checkup giants continue to debate whether they should be held responsible for low-cost packages, early screening technology has quietly bridged the cost-effectiveness gap.
HymonBio’s mission is clear: to ensure that every blood test is worthy of giving life.
After all, when it comes to cancer, early detection offers a much greater chance of survival—this shouldn’t be a privilege reserved for the wealthy, but a fundamental right for everyone!
Post time: Aug-01-2025